Tags |
|
|
Links |
|
|
Answers - Evaluating a Finance Lender
When most of us need some extra cash for an upcoming project, the first thing we think about is heading down to the local ba
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
nk and getting a loan. While this may work just fine in some cases, you may not always get the best rate of interest or the
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
most favorable repayment terms. In order to do that, you may have to investigate more than one finance lender. Here are so
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
me tips to help you properly evaluate potential lenders.
One of the first things you want to look at is stability. Banks u
One of the first things you want to look at is stability. Banks u
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ually have the upper hand on this one, since most of them have been around for many years and can demonstrate their stabilit
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
y simply by their ongoing presence in the area. Finance companies may not be able to demonstrate their stability in quite t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
e same manner. If you are thinking of going with a finance company, do some digging into their background. You will want t
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
o know when the company started, at least some basic ideas of how they do business and also are they stable in their operati
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ns. You can get a lot of this information from the company itself, but you can also check with records available at the loc
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
al court house to determine if this finance company is one you should consider doing business with.
Along with stability, y
Along with stability, y
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
u want to learn all you can about the reputation of the company. Ideally, you want one that has a number of happy customers
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
. A good finance lender knows how to be honest with a client and will do everything they can to keep the customer happy, wi
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
hin the boundaries of the operating guidelines of the institution. If possible, talk with people who have done business wit
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
h them before. Get their perceptions on such matters as how well they explained the terms of the loan, how easy it is to re
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ch someone if a question came up, and also if the lenders were personable and still professional. All these factors come in
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
to play if you want to deal with a lender who will have your best interests at heart.
Finally, trust your own gut feeling.
Finally, trust your own gut feeling.
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
If your interview with a finance lender leaves something to be desired, then you may want to keep looking for another option
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
. Not everyone is a perfect match, so it may just be that you would work better with someone else. Don't allow yourself to
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
be swayed into something that your instincts tell you is not the right deal for you. Consider your hunches as well as the d
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ata you can collect about the finance lender from other sources. In the long run, you will be much happier with your choice
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/105260/answers-Evaluating-a-Finance-Lender.html">Evaluating a Finance Lender</a>
BB link (for phorums):
[url=http://www.answers.org.ua/article/105260/answers-Evaluating-a-Finance-Lender.html]Evaluating a Finance Lender[/url]
Related Articles:
Get Your Emails to Work for You - 2
What Would Be The Magic Internet Business Plan To Make Your Online Business Successful?
Bookmark it:
|